These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16307894)

  • 41. Characterization of a novel cry8 gene specific to Melolonthidae pests: Holotrichia oblita and Holotrichia parallela.
    Shu C; Yan G; Wang R; Zhang J; Feng S; Huang D; Song F
    Appl Microbiol Biotechnol; 2009 Sep; 84(4):701-7. PubMed ID: 19399496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyt2Ba of Bacillus thuringiensis israelensis: activation by putative endogenous protease.
    Nisnevitch M; Cohen S; Ben-Dov E; Zaritsky A; Sofer Y; Cahan R
    Biochem Biophys Res Commun; 2006 May; 344(1):99-105. PubMed ID: 16630537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
    Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
    J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification of a bioactive recombinant human Reg IV expressed in Escherichia coli.
    Hu G; Shen J; Cheng L; Xiang D; Zhang Z; He M; Lu H; Zhu S; Wu M; Yu Y; Wang X; Han W
    Protein Expr Purif; 2010 Feb; 69(2):186-90. PubMed ID: 19699332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single pH buffer refolding screen for protein from inclusion bodies.
    Coutard B; Danchin EG; Oubelaid R; Canard B; Bignon C
    Protein Expr Purif; 2012 Apr; 82(2):352-9. PubMed ID: 22343064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hydrophobic interaction expanded bed adsorption chromatography (HI-EBAC) based facile purification of recombinant streptokinase from E. coli inclusion bodies.
    Goyal D; Sahoo DK; Sahni G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):384-91. PubMed ID: 17188946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial activity of different proteins and their fragments from Bacillus thuringiensis parasporal crystals against clostridia and archaea.
    Yudina TG; Brioukhanov AL; Zalunin IA; Revina LP; Shestakov AI; Voyushina NE; Chestukhina GG; Netrusov AI
    Anaerobe; 2007 Feb; 13(1):6-13. PubMed ID: 17126041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
    Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Optimization of induction and purification of HIV-1 Gag protein in Escherichia coli expression system].
    Fu J; Sun J; Chen P; Huo Z; Hao Y; Liu Y
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1306-11. PubMed ID: 18837413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Asn183 in alpha5 is essential for oligomerisation and toxicity of the Bacillus thuringiensis Cry4Ba toxin.
    Likitvivatanavong S; Katzenmeier G; Angsuthanasombat C
    Arch Biochem Biophys; 2006 Jan; 445(1):46-55. PubMed ID: 16356469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates.
    de Groot NS; Ventura S
    J Biotechnol; 2006 Aug; 125(1):110-3. PubMed ID: 16621081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cloning and expression of nematicidal crystal protein gene cry6Aa of Bacillus thuringiensis].
    Yu ZQ; Bai PS; Guo SX; Yu ZN; Sun M
    Wei Sheng Wu Xue Bao; 2007 Oct; 47(5):865-8. PubMed ID: 18062264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Purification and on-column refolding of EGFP overexpressed as inclusion bodies in Escherichia coli with expanded bed anion exchange chromatography.
    Cabanne C; Noubhani AM; Hocquellet A; Dole F; Dieryck W; Santarelli X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):23-7. PubMed ID: 15722040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli.
    Patra AK; Mukhopadhyay R; Mukhija R; Krishnan A; Garg LC; Panda AK
    Protein Expr Purif; 2000 Mar; 18(2):182-92. PubMed ID: 10686149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression and purification of biologically active rat bone morphogenetic protein-4 produced as inclusion bodies in recombinant Escherichia coli.
    Klösch B; Fürst W; Kneidinger R; Schuller M; Rupp B; Banerjee A; Redl H
    Biotechnol Lett; 2005 Oct; 27(20):1559-64. PubMed ID: 16245174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amino acid substitutions in alphaA and alphaC of Cyt2Aa2 alter hemolytic activity and mosquito-larvicidal specificity.
    Promdonkoy B; Rungrod A; Promdonkoy P; Pathaichindachote W; Krittanai C; Panyim S
    J Biotechnol; 2008 Feb; 133(3):287-93. PubMed ID: 18054404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cloning and expression of Bacillus phytase gene (phy) in Escherichia coli and recovery of active enzyme from the inclusion bodies.
    Rao DE; Rao KV; Reddy VD
    J Appl Microbiol; 2008 Oct; 105(4):1128-37. PubMed ID: 18479345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli.
    Tan H; Dan G; Gong H; Cao L
    Biotechnol Lett; 2005 Aug; 27(16):1177-82. PubMed ID: 16158260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolation and characterization of strain of Bacillus thuringiensis subsp. kenyae containing two novel cry1-type toxin genes.
    Choi JY; Li MS; Shim HJ; Roh JY; Woo SD; Jin BR; Boo KS; Je YH
    J Microbiol Biotechnol; 2007 Sep; 17(9):1498-503. PubMed ID: 18062228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-throughput recovery of therapeutic proteins from the inclusion bodies of Escherichia coli: an overview.
    Panda AK
    Methods Mol Biol; 2005; 308():155-61. PubMed ID: 16082033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.